Downstream Processing Market Revenue Estimated to Grow at a CAGR of 16.4%

The global downstream processing market is poised to reach $22.03 Billion by 2021 from $10.32 Billion in 2016, at a CAGR of 16.4%. The growth of this market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging …

Downstream Processing Market: Increasing Demand for Biopharmaceuticals

The Asia-Pacific region is expected to offer huge growth opportunities in Downstream Processing Market . Countries like China, Japan, India, and South Korea, are expected to drive the demand for downstream processing products in the coming years. Also, growth in these markets will be fueled …

Downstream Processing | An Emerging Market with Attractive Growth Opportunities

What is the future growth analysis of global Downstream Processing Market? The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% What are key factors driving growth of global Downstream …

Most Effective Growth Strategies Adopted by Key Players in Downstream Processing Market

The downstream processing market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.). In the downstream processing market, the major players are Thermo Fisher Scientific Inc. (U.S.), …